Fox Chase International

Clinical Trials

Clinical Trials

Phase 1 Clinical Trials
Read more »

Molecular Medicine

Molecular Medicine

Molecular Medicine at Fox Chase
Read more »

Biosample Repository

Biosample Repository

Collection and distribution of human subject biosamples.
Read more »

By The Numbers

A Century of Excellence

National rankings, accreditations, awards. The numbers are in your favor.
Read more »

Faculty Summaries

Fox Chase Cancer Center International (“Fox Chase International”) is an endeavor created to align the exceptional skills and resources of cancer research, diagnosis and treatment resident at Fox Chase with the oncology training, diagnosis and treatment requirements internationally.  Fox Chase International wants to support hospitals that require skill, expertise and training in treating cancers that have significant demand for services and the funding to pay for services, but lack these assets and align them with the available expertise resident in Fox Chase.

Fox Chase International has the ability to contract for services with leading hospitals internationally that would seek to contract for virtual diagnosis and treatment services, consultation as cancer centers are established, physician and nurse training and potentially the establishment of tissue banks. The mission of Fox Chase International is to provide US oncology expertise by providing specialized support resulting in defining advanced standard for prevention, high-risk assessment and diagnosis and management as well as related training and administrative services. The purpose of the venture is to collaborate to raise the skills in cancer diagnosis and multidisciplinary management in solid tumors, particularly Breast, Lung and GI Malignancies. The collaboration with Fox Chase experts in these fields will contribute to establish novel standards and train physicians and support personnel with the goal to improve the recovery rates for cancer patients globally and to establish world-class cancer centers internationally.

Fox Chase International has existing relationships with Benxi Central Hospital, which has asked to establish a formal affiliation including physician training, on-site assessment of oncology activities, and consultation on building an Asia Cancer Center in Benxi; the People’s Liberation Army Hospital 307 to which Fox Chase formally provides second opinions and treatment plans, Qiqihar Medical Hospital, with which we have established a formal affiliation that includes physician training and on-site assessment of oncology activities, and ShanghaiBio, a China-based corporation that performs specialty R&D services for global pharma/biotech companies that plans to license Fox Chase protocols for all Clinical Molecular Genetics Laboratory tests and has agreed to introduce Fox Chase to its 40+ partner hospitals. Fox Chase International and Star Health Network have also submitted a proposal to collaborate with Surya Pharmaceuticals to build a Center of Excellence (COE) in Oncology in Chandigarh, India.

Fox Chase International is led by Kurt Schwinghammer, Ph.D., as president, Charlie Ma, Ph.D., as chief scientific officer, and Amin Chisti as vice president of operations. Additionally, Paul Engstrom, M.D., has agreed to serve as an international ambassador for Fox Chase International, leveraging his many professional relationships around the world in support of the new effort.